References
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(14): 977–86
- Ratzmann KP. The psychological aspects of diabetics with secondary failure of sulfonylurea therapy. Dtsch Med Wochenschr 1991; 116(3): 87–90
- Wilkinson G. The influence of psychiatric, psychological and social factors on the control of insulin-dependent diabetes mellitus. J Psychosom Res 1987: 31 (3): 277–86
- Edelstein J, Linn MW. The influence of the family on control of diabetes. Soc Sei Med 1985; 21(5): 541–4
- Lundman B, Norberg A. Coping strategies in people with insulin-dependent diabetes mellitus. Diabetes Educ 1993; 19(3): 198–204
- Rubin RR, Peyrot M, Saudek CD. Effect of diabetes education on self-care, metabolic control, and emotional well-being. Diabetes Care 1989; 12(10): 673–9
- Cerkoney KA, Hart LK. The relationship between the health belief model and compliance of persons with diabetes mellitus. Diabetes Care 1980; 3(5): 594–8
- Wooldridge KL, Wallston KA, Graber AL, et al. The relationship between health beliefs, adherence, and metabolic control of diabetes. Diabetes Educ 1992; 18(6): 495–500
- The Diabetes Control and Complications Trial Research Group. Weight gain associated with intensive therapy in the Diabetes Control and Complications Trial. Diabetes Care 1988; 11(7): 567–73
- Yki-Jarvinen H, Kauppila M, Kujansuu E, et al. Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1992: 327(20): 1426–33
- Rodin GM, Daneman D. Eating disorders and IDDM: a problematic association. Diabetes Care 1992; 15(10): 1402–12
- Amiel SA, Tamborlane WV, Simonson DC, et al. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med 1987; 316(22): 1376–83
- Wredling RA, Theoreil PG, Roll HM, et al. Psychosocial state of patients with IDDM prone to recurrent episodes of severe hypoglycemia. Diabetes Care 1992; 15(4): 518–21
- Auer RN, Olsson Y, Siesjo BK. Hypoglycemic brain injury in the rat. Correlation of density of brain damage with the EEG isoelectric time: a quantitative study. Diabetes 1984; 33(11): 1090–8
- Jacobson AM, Adler AG, Wolfsdorf JI et al. Psychological characteristics of adults with IDDM: comparison of patients in poor and good glycemic control. Diabetes Care 1990; 13(4): 375–81
- Glasgow RE, McCaul KD, Schafer LC. Self-care behaviors and glycemic control in type I diabetes. J Chronic Dis 1987; 40(5): 399–412
- Sulway M, Tupling H, Webb K, et al. New techniques for changing compliance in diabetes. Diabetes Care 1980; 3(1): 108–11
- Hurley AC. The health belief model: evaluation of a diabetes scale. Diabetes Educ 1990; 16(l): 44–8
- Beaser RS. Fine-tuning insulin therapy. Postgrad Med 1992; 91(4): 323–30
- Hirsch IB, Farkas-Hirsch R, Skyler JS. Intensive insulin therapy for treatment of type I diabetes. Diabetes Care 1990; 13(12): 1265–83
- Howey DC, Bowsher RR, Brunelle RL, et al [Lys(B28), Pro(B29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 1994; 43(3): 396–402
- Vignati L, Anderson J, Brunelle R. Efficacy of [Lys(B28), Pro(B29)]-human insulin in a one year global randomized clinical trial. (Personal communication) Eli Lilly and Company, Indianapolis
- Selam JL, Charles MA. Devices for insulin administration. Diabetes Care 1990; 13 (9): 955–79 [Erratum, Diabetes Care 1991; 14(4): 353]
- Denne JR, Andrews KL, Lees DV, et al A survey of patient preference for insulin jet injectors versus needle and syringe. Diabetes Educ 1992; 18(3): 223–7
- Peters AL, Davidson MB. Insulin plus a sulfonylurea agent for treating type 2 diabetes. Ann Intern Med 1991; 115(l): 45–53